Related Experiment Videos
Secondary prevention of coronary heart disease in older patients after the national service framework: population
Sheena E Ramsay1, Peter H Whincup, Debbie A Lawlor
1Department of Primary Care and Population Sciences, Royal Free and University College Medical School, London NW3 2PF. s.ramsay@pcps.ucl.ac.uk
Insights
Medication use for secondary prevention of coronary heart disease increased in older British adults, with significant gains in statin prescriptions. However, uptake of beta blockers and ACE inhibitors remains suboptimal, especially for angina patients.
Area of Science:
- Cardiology
- Geriatric Medicine
- Public Health
Background:
- Secondary prevention of coronary heart disease (CHD) is crucial for reducing recurrent events in older adults.
- The National Service Framework aimed to improve CHD care in the UK.
Purpose of the Study:
- To assess the uptake of secondary prevention medications for CHD in older British men and women.
- To compare medication use before and after the implementation of the National Service Framework for CHD.
Main Methods:
- Two population-based, longitudinal studies were conducted in 20 British towns.
- Participants included men and women aged 60-79 with established CHD.
- Prevalence of antiplatelet, statin, beta blocker, ACE inhibitor, and blood pressure-lowering drug use was assessed.
Main Results:
- Between 1998-2001 and 2003, the use of all individual medications increased, notably statins.
- Statin use rose from 34% to 65% in men and 48% to 67% in women with myocardial infarction.
- Less than half of patients received beta blockers and ACE inhibitors by 2003, with lower use in angina patients compared to myocardial infarction patients.
Conclusions:
- Statin uptake and combined drug treatment significantly increased in elderly patients between 1998-2001 and 2003.
- Opportunities exist to further reduce recurrent CHD risk by improving medication uptake in angina patients.
- Increased use of blood pressure-lowering treatments, particularly beta blockers and ACE inhibitors, is recommended.
Objective:
To examine the extent of uptake of medication for secondary prevention of coronary heart disease in older British men and women before (1998-2001) and after (2003) the implementation of the national service framework.
Design:
Two population based, longitudinal studies of men and women aged 60-79 in 1998-2001, based in one general practice in each of 24 British towns.
Participants:
Men and women with established coronary heart disease at the two time points (respectively 817 and 465 in 1998-2001, 857 and 548 in 2003), aged 60-79 in 1998-2001.
Main Outcome Measures:
Prevalence of use of antiplatelet medication, statins, beta blockers, angiotensin converting enzyme (ACE) inhibitors, and other blood pressure lowering treatments (individually and in combination) assessed in 1998-2001 and 2003.
Results:
Between 1998-2001 and 2003, the use of all individual drugs had increased in both men and women, especially for statins (from 34% to 65% in men and from 48% to 67% in women with myocardial infarction). However, less than half received beta blockers and ACE inhibitors, even by 2003. Prevalences of medication use were lower in patients with angina than in those with myocardial infarction. The proportions of patients receiving more than one drug increased over time; by 2003 about half of patients with myocardial infarction and a third of those with angina were receiving antiplatelet medication, statins, and blood pressure lowering treatments.
Conclusions:
Between 1998-2001 and 2003, statin uptake and the use of combined drug treatment in elderly men and women increased markedly. Further potential exists, however, for reducing the risk of recurrent coronary heart disease in older patients, particularly by improving the uptake of medication among angina patients, and by more extensive use of blood pressure lowering treatment (particularly with beta blockers and ACE inhibitors).
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Preventive Healthcare Services
Atherosclerosis III: Management
Coronary Artery Disease I: Introduction